Pizzorno A - Search Results

1

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.

Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A, Roche M, Hamelin ME, Rhéaume C, Croze S, Escuret V, Poissy J, Lina B, Legras-Lachuer C, Textoris J, Boivin G, Rosa-Calatrava M. Pizzorno A, et al. Front Immunol. 2019 Jan 29;10:60. doi: 10.3389/fimmu.2019.00060. eCollection 2019. Front Immunol. 2019. PMID: 30761132 Free PMC article.

2

Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Pizzorno A, Bouhy X, Abed Y, Boivin G. Pizzorno A, et al. J Infect Dis. 2011 Jan 1;203(1):25-31. doi: 10.1093/infdis/jiq010. J Infect Dis. 2011. PMID: 21148493 Free PMC article.

3

Influenza drug resistance.

Pizzorno A, Abed Y, Boivin G. Pizzorno A, et al. Semin Respir Crit Care Med. 2011 Aug;32(4):409-22. doi: 10.1055/s-0031-1283281. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858746 Review.

4

The 2009 pandemic H1N1 D222G hemagglutinin mutation alters receptor specificity and increases virulence in mice but not in ferrets.

Abed Y, Pizzorno A, Hamelin ME, Leung A, Joubert P, Couture C, Kobasa D, Boivin G. Abed Y, et al. Among authors: pizzorno a. J Infect Dis. 2011 Oct 1;204(7):1008-16. doi: 10.1093/infdis/jir483. J Infect Dis. 2011. PMID: 21881115

5

Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.

Abed Y, Pizzorno A, Bouhy X, Boivin G. Abed Y, et al. Among authors: pizzorno a. PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8. PLoS Pathog. 2011. PMID: 22174688 Free PMC article.

6

Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.

Pizzorno A, Abed Y, Bouhy X, Beaulieu E, Mallett C, Russell R, Boivin G. Pizzorno A, et al. Antimicrob Agents Chemother. 2012 Mar;56(3):1208-14. doi: 10.1128/AAC.05994-11. Epub 2011 Dec 27. Antimicrob Agents Chemother. 2012. PMID: 22203589 Free PMC article.

7

Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Abed Y, Pizzorno A, Boivin G. Abed Y, et al. Among authors: pizzorno a. Antimicrob Agents Chemother. 2012 Aug;56(8):4375-80. doi: 10.1128/AAC.00753-12. Epub 2012 Jun 4. Antimicrob Agents Chemother. 2012. PMID: 22664977 Free PMC article.

8

Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.

Pizzorno A, Abed Y, Rhéaume C, Bouhy X, Boivin G. Pizzorno A, et al. Antimicrob Agents Chemother. 2013 Apr;57(4):1784-9. doi: 10.1128/AAC.02269-12. Epub 2013 Jan 28. Antimicrob Agents Chemother. 2013. PMID: 23357777 Free PMC article.

9

Influenza virus resistance to neuraminidase inhibitors.

Samson M, Pizzorno A, Abed Y, Boivin G. Samson M, et al. Among authors: pizzorno a. Antiviral Res. 2013 May;98(2):174-85. doi: 10.1016/j.antiviral.2013.03.014. Epub 2013 Mar 22. Antiviral Res. 2013. PMID: 23523943 Review.

10

Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

Abed Y, Pizzorno A, Bouhy X, Rhéaume C, Boivin G. Abed Y, et al. Among authors: pizzorno a. J Virol. 2014 Feb;88(3):1652-8. doi: 10.1128/JVI.02681-13. Epub 2013 Nov 20. J Virol. 2014. PMID: 24257597 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters